Matthias Farlik

Medical University of Vienna — Austria

Medicine · Health Sciences

41h-index7.7kcitations171works8.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cutaneous lymphoproliferative disorders research(36), Lymphoma Diagnosis and Treatment(33), CAR-T cell therapy research(23), Immune Cell Function and Interaction(17), Histiocytic Disorders and Treatments(16)

Publications171 total

305 Comprehensive Multi-Omics Profiling Reveals HPyV9 Infection in a Case of Granulomatous and Hyperkeratotic Dermatosis
Journal of Investigative Dermatology·2025
181 JAK1/2 inhibition reprograms the T cell compartment to facilitate resolution of scarring alopecia
Journal of Investigative Dermatology·2025
184 Skin-resident memory T cell subset balance is disrupted by perturbation of tissue homeostasis
Journal of Investigative Dermatology·2025Open Access
A stem cell differentiation model reveals two alternative fates in CBFA2T3::GLIS2-driven acute megakaryoblastic leukemia initiation
Communications Biology·2025Open Access
Integrated time-series analysis and high-content CRISPR screening delineate the dynamics of macrophage immune regulation
Cell Systems·2025· 2 citedOpen Access
Heterogeneity of IL-15-expressing mesenchymal stromal cells controls natural killer cell development and immune cell homeostasis
Nature Communications·2025· 2 citedOpen Access
Abstract 2598: Fatty origins of a bone tumor? The curious case of Ewing Sarcoma
Cancer Research·2025
Abstract 1304: A novel organoid-based model to study pediatric tumor metastasis to the lung
Cancer Research·2025
Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial
Medical Microbiology and Immunology·2025Open Access
Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions
Cellular and Molecular Life Sciences·2025· 3 citedOpen Access
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial)
Nature Cancer·2025· 10 citedOpen Access
Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions
2024Open Access
LTβR deficiency causes lymph node aplasia and impaired B cell differentiation
Science Immunology·2024· 8 citedOpen Access
JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
EMBO Molecular Medicine·2024· 11 citedOpen Access
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures
Journal for ImmunoTherapy of Cancer·2024· 17 citedOpen Access
Dysfunctional tumor-infiltrating Vδ1 + T lymphocytes in microsatellite-stable colorectal cancer
Nature Communications·2024· 20 citedOpen Access
734 scRNAseq characterization of primary cutaneous B-cell lymphomas compared to their systemic counterparts
Journal of Investigative Dermatology·2024Open Access
Reproducibility of LPS-Induced ex vivo Cytokine Response of Healthy Volunteers Using a Whole Blood Assay
Journal of Inflammation Research·2024· 5 citedOpen Access
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations
Nature Communications·2024· 16 citedOpen Access
Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells
Blood·2024· 9 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Christoph Bock(29), Florian Halbritter(12), Lisa E. Shaw(11), Wolfgang Weninger(10), Thomas Decker(8), Johanna Klughammer(7), Mathias Müller(7), Nikolaus Fortelny(7), Veronika Sexl(7), Thomas Penz(6), Stefan Kubicek(6), Tibor Harkany(5), Christian Schmidl(5), Roman A. Romanov(4), Erik Keimpema(4), André F. Rendeiro(4), Claus Vogl(4), Katharina Rindler(4), Constanze Jonak(4), Wolfgang Bauer(4)